Top Story

Apellis to acquire Potentia Pharmaceuticals

November 21, 2014

Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals, according to a press release.

Through the agreement, Apellis obtained the necessary intellectual property rights to develop a complement inhibitor drug compound (APL-2) for the treatment of dry age-related macular degeneration.

thumbnail for video 3903679109001 Meeting News CoverageVideo

VIDEO: Management of zonular dehiscence

November 21, 2014
NEW YORK — At OSN New York 2014, Cynthia Matossian, MD, discusses strategies for handling cases of zonular dehiscence in cataract surgery.

Imprimis reports $2.5 million net loss in third quarter

November 21, 2014
Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million, or $0.23 per common…

Ocular Therapeutix to evaluate sustained-release travoprost for glaucoma, ocular hypertension

November 21, 2014
Ocular Therapeutix has begun enrolling the first subjects in a phase 2b clinical trial to evaluate the safety and efficacy of sustained-release travoprost, according to…

Valeant announces $2 billion Securities Repurchase Program

November 20, 2014
A new securities repurchase program that will allow Valeant Pharmaceuticals to make purchases up to $2 billion of its senior notes, common shares and other securities…
More News Headlines »
Review

The Use of Femtosecond Lasers in Cataract Surgery: Review of the Published Results With the LenSx System

Journal of Refractive Surgery, November 2014, Volume 30 Issue 11
To review the published literature describing the use of the LenSx femtosecond laser technology (Alcon Laboratories…
More »
CME
In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD

In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

Dry age-related macular degeneration has proven to be a challenging condition for clinicians, and no pharmaceutical…
More »
Meeting News Coverage Video
thumbnail for video 3900080232001

Surgeon gives pearls for dislocated IOLs

November 19, 2014
NEW YORK — At the OSN New York meeting here, Uday Devgan, MD, discusses pearls for properly diagnosing and…
More »
morganatic-roan